IFF (NYSE: IFF) today unveiled the next phase in the evolution
of its Board of Directors, aimed at bolstering the company's
long-term strategic vision and driving profitable market share
growth.
New Board Chair: Kevin O’Byrne—an experienced IFF board
member and chair of Centrica plc—will become Board Chair at the
2025 Annual Shareholder Meeting. O’Byrne will succeed Roger W.
Ferguson, Jr. who has served as Chair since 2022. Ferguson notified
IFF of his intent to not stand for reelection at the 2025 Annual
Shareholder Meeting after 14 years of distinguished service.
Board Appointments: Cynthia Jamison, Dr. Mehmood Khan and
Vincent Intrieri will join the Board of Directors effective Jan. 1,
2025. Intrieri’s appointment is at the request of Icahn Capital LP
pursuant to the Cooperation agreement. He replaces Gary Hu, who
will step down from the IFF Board on Dec. 31, 2024.
Board Retirements: Christina Gold and John Davidson have
announced their plans to not stand for reelection at the 2025
Annual Shareholder Meeting. When these departures are in effect,
IFF will have ten board members.
“It has been an incredible honor and privilege to serve on the
IFF Board,” said Ferguson. “IFF has the right leaders in place, a
dynamic team fueled by science and creativity, plus a world-class
portfolio backed by a cutting-edge R&D pipeline. The Company is
very well placed to meet the needs of its customers, powering
everyday products for tomorrow’s consumers. I am very proud of the
strong progress in the last twelve months and excited to see IFF
build on this momentum in the coming years. I want to thank Erik
and the entire team at IFF for their commitment and support.”
“We are grateful for Roger, Christina, John and Gary's
invaluable contributions to strengthening IFF,” said Erik Fyrwald,
IFF CEO and director. “As we author our next chapter, I look
forward to working with Kevin in his new role. I am delighted to
welcome Cindie, Mehmood and Vince to the board. Their expertise,
experience and insights will support us in unlocking our full
potential to serve our customers, deliver innovative, sustainable
solutions, and profitably grow IFF.”
About Cynthia Jamison
Cynthia “Cindie” Jamison is a seasoned executive with more than
two decades of corporate boardroom and financial leadership
experience. She currently chairs the boards of Darden Restaurants
and Big Lots, and previously chaired Tractor Supply Co.
Before focusing on board service, Jamison was the CFO of
AquaSpy, Inc. and held CFO roles at various companies during
periods of growth or turnaround. From 1999-2009, she was a managing
partner at Tatum LLP, leading the CFO Services practice and
overseeing more than 400 CFOs nationally. She also served as CFO or
COO for several companies, including eMac, Inc., Cosi, Inc.,
SurePayroll and Illinois Superconductor.
Her earlier career includes roles at Chart House Enterprises,
Allied Domecq Retailing USA, Kraft General Foods and Arthur
Andersen LLP.
Jamison is recognized as an expert in financial and economic
issues, frequently speaking on topics related to CFOs and board
governance. She has been quoted in Forbes, The Wall Street Journal,
Newsweek and The Economist. She is an NACD Board Leadership Fellow
named among the NACD D100.
About Mehmood Khan
Dr. Mehmood Khan is the CEO of Hevolution Foundation, a
first-of-its-kind global non-profit organization with a mission to
extend healthy lifespan for people everywhere. Hevolution provides
grants and early-stage company investments to incentivize
independent research and entrepreneurship in the emerging field of
healthspan science. The organization aims to increase the number of
safe and effective treatments entering the market, compress the
timeline of drug development using the latest tools and
technologies, and increase accessibility to therapeutics.
Hevolution has committed more than $400 million in grants,
partnerships and early-stage biotech investments in just over two
years, making it the world’s largest philanthropic healthspan
science funder.
Dr. Khan is a member of the Board of Directors of Reckitt
Benckiser and the Saudi Research, Development, and Innovation
Authority and the Saudi National Biotechnology Strategy Steering
Committee.
He previously served as a Chairman of the Visiting Committee on
Advanced Technology of the United States’ National Institute of
Standards and Technology, and as the Executive Chair of Life
Biosciences after serving as the CEO from 2019-2024. Life
Biosciences is based in Boston and leverages a platform approach to
develop therapeutics that can reverse and prevent multiple
age-related conditions.
Prior to this role, Dr. Khan served as PepsiCo’s Vice Chairman
and Chief Scientific Officer of Global Research and Development.
With net revenues of more than $64 billion in 2018, Dr. Khan
oversaw the PepsiCo global Performance with Purpose sustainability
initiatives, inspired by the fundamental belief that business
success is inextricably linked to the sustainability of the world
we share. He led PepsiCo’s research and development efforts,
creating breakthrough innovations in food, beverages and
nutrition—as well as delivery, packaging and production
technology—to capture competitive advantage and drive PepsiCo’s
businesses forward.
Prior to joining PepsiCo, Dr. Khan was President of Takeda
Global Research & Development Center, overseeing Takeda
Pharmaceuticals Company’s worldwide R&D efforts. He was also a
faculty member at the Mayo Clinic and Mayo Medical School in
Rochester, Minn., serving as Director of the Diabetes, Endocrine
and Nutritional Trials Unit in the endocrinology division. He also
spent nine years leading programs in diabetes, endocrinology,
metabolism and nutrition for the Hennepin County Medical Center in
Minneapolis. He is a Fellow of the Royal College of Physicians in
London, a Fellow of the American College of Endocrinology and an
Elected Fellow in the Department of Pharmacology at University of
Oxford.
About Vincent Intrieri
Vince Intrieri is the founder and CEO of VDA Capital Management
LLC, a private investment fund established in 2017. Intrieri
previously worked for Carl Icahn-related entities in various
investment roles from 1998 to 2016, including serving as senior
managing director of Icahn Capital LP from 2008 to 2016.
Intrieri is currently a Director of Transocean Ltd, Hertz Global
Holdings and Chairman of the Board of Sandridge Energy Inc. His
past directorships include Navistar International Corp., Energen
Corp., Conduent Inc., Chesapeake Energy Corp., CVR Refining GP LLC,
Ferrous Resources Ltd., Forest Laboratories Inc., CVR Energy Inc.,
Federal-Mogul Holdings Corp., Icahn Enterprises LP, Dynegy Inc.,
PSC Metals, Motorola Solutions Inc., XO Holdings, National Energy
Group, American Railcar Industries, WestPoint Home LLC and Viskase
Companies Inc.
Intrieri graduated with distinction from Pennsylvania State
University with a B.S. in accounting in 1984 and was a certified
public accountant.
Welcome to IFF
At IFF (NYSE: IFF), we make joy through science, creativity and
heart. As the global leader in flavors, fragrances, food
ingredients, health and biosciences, we deliver groundbreaking,
sustainable innovations that elevate everyday products—advancing
wellness, delighting the senses and enhancing the human experience.
Learn more at iff.com, LinkedIn, Instagram and Facebook.
© 2024 by International Flavors & Fragrances Inc. IFF is a
Registered Trademark. All Rights Reserved.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241219567125/en/
Media Relations: Paulina Heinkel 332.877.5339
Media.request@iff.com Investor Relations: Michael Bender
212.708.7263 Investor.Relations@iff.com
International Flavors an... (NYSE:IFF)
Historical Stock Chart
From Nov 2024 to Dec 2024
International Flavors an... (NYSE:IFF)
Historical Stock Chart
From Dec 2023 to Dec 2024
